Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target

scientific article published in February 2004

Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1309/K144PHVDDUPDD401
P698PubMed publication ID14983936

P50authorChristine A Iacobuzio-DonahueQ58327762
P2093author name stringRaheela Ashfaq
Lynette S Nichols
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectpancreatic cancerQ212961
P304page(s)226-230
P577publication date2004-02-01
P1433published inAmerican Journal of Clinical PathologyQ15750224
P1476titleClaudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target
P478volume121

Reverse relations

cites work (P2860)
Q89077427Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer
Q34788669C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin
Q33814933Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
Q42476256Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia
Q58001856Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma
Q37611453Claudin and ovarian cancer
Q54646160Claudin expression in Barrett's esophagus and adenocarcinoma.
Q80148403Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas
Q28287255Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study
Q30491616Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response
Q40355382Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas
Q33967794Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression
Q36244220Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer
Q35756974Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin
Q39335167Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions
Q39651156Claudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rate.
Q35681850Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder
Q37400120Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma
Q47157718Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging.
Q40164661Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer
Q40257166DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.
Q53565622Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.
Q45717757Detection of claudin-4 in salivary gland neoplasms (a study utilizing RT-PCR and immunohistochemistry).
Q61773593Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12
Q36796253Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas
Q28507165Dynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformation
Q37225107Emerging roles of claudins in human cancer
Q84290461Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival
Q39628515Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas.
Q30437572Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis
Q37338056Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion
Q37696662Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue
Q40795286Gene expression profiles associated with advanced pancreatic cancer.
Q33526567High-resolution light microscopy using luminescent nanoparticles
Q36858042Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
Q47903216Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Q33412483Imaging pancreatic cancer using bioconjugated InP quantum dots
Q37386754Immobilization of biomolecules on the surface of inorganic nanoparticles for biomedical applications
Q51547379Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Q42476044Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia
Q64890641MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature.
Q30393523Molecular Imaging of Pancreatic Cancer with Antibodies
Q36485336Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts
Q33543746Multifunctional Nanoparticles as Biocompatible Targeted Probes for Human Cancer Diagnosis and Therapy
Q48293480Nanotechnologies in Pancreatic Cancer Therapy
Q30489770New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.
Q33834277Non-invasive tumor detection in small animals using novel functional Pluronic nanomicelles conjugated with anti-mesothelin antibody.
Q35582711Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma
Q36773924Overexpression of claudin-4 may be involved in endometrial tumorigenesis
Q26787279Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis
Q37370600Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status
Q30458493Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging
Q51735492Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging.
Q35965742Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots
Q38821198Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers
Q37038590Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.
Q47633338Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Q36685675Target discovery and validation in pancreatic cancer
Q21260426The claudin gene family: expression in normal and neoplastic tissues
Q48002827The prognostic role of claudins in head and neck squamous cell carcinomas
Q38223244The role of epithelial tight junctions involved in pathogen infections
Q55483367Therapeutic antibodies for the treatment of pancreatic cancer.
Q38957238Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers
Q51476559Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions.

Search more.